Characteristics of Immunological Non-Responders in People Living with HIV at Abepura Hospital Papua
DOI:
https://doi.org/10.24293/ijcpml.v30i3.2210Keywords:
Immunological non-responders, CD4, HIVAbstract
Infection of Human Immunodeficiency Virus (HIV) lowers the body's immune system, especially CD4+ cells, making it more susceptible to opportunistic infections. Approximately 10-40% of People Living with HIV/AIDS (PLHIV) fail to achieve normal levels of CD4+ T cells despite continued virological suppression, a condition called Immunological Non-Responders (INR). Previous studies have shown that INR is considered a predictor of disease progression in people with HIV receiving antiretroviral (ARV)s through various mechanisms of suppression of the immune system that increases morbidity and mortality. Papua is an HIV epidemic area with a prevalence of 2.3%. This research is a cohort study conducted at Abepura Hospital from June 2019 to February 2023, which aims to identify the factors that influence the occurrence of INR in PLHIV receiving ARV therapy. There were 123 research subjects consisting of 55 people (44.7%) in the INR group and 68 people (55.3%) in the non-INR group. The results showed that the incidence of INR was higher in males than females (p=0.019), INR was significantly associated with increasing age (p=0.013), and CD4 count was low at the start of ARVs (p=0.002). There was a significant difference in CD4 counts between INR and non-INR (p<0.001). Oral candidiasis as a common opportunistic infection is more common in people with INR than in non-INR. (p=0.037). This study suggested that it is necessary to carry out a CD4 examination at the start of therapy and monitoring every 6 months to detect possible INR to prevent an increased risk of AIDS and non-AIDS, which increases mortality.
Downloads
References
Peraturan Menteri Kesehatan no 23, 2022. Penanggulangan human immunodeficiency virus, acquired immune deficiency syndrome dan infeksi menular seksual. Jakarta, 2022; 23: 001-118.
Yang X, Su B, Zhang T, Zhang X, Liu Y, Wu H. Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non-responderss. J Leukoc Biol, 2020; 107: 597–612.
Bono V, Augello M, Tincati C, Marchetti G. Failure of CD4+ T-cell recovery upon virally-effective cART: An enduring gap in the understanding of HIV+ immunological non-responders. New Microbiol, 2022; 45(3): 155–72.
Hailu, Araya W. Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia. BMC Infectious Diseases, 2021; 21: 561.
Adi N, Allahna E, Xun W, Emmanuel B, Yakubu A, et al. Clinical factors and outcomes associated with immune non response among virally suppressed adults with HIV from Africa and the United States. Scientific Reports, 2022; 12: 1196.
Aiwei Z, Fernando R, Jaja Z, Se G, Pierre de T, et al. HIV sheltering platelets from immunological non-responders induce a dysfunctional glycolytic CD4 T cell profile. Frontiers in Immunology, 2022; 2: 78192.
Mora EG, Massanella M, Garcia E, Giles D, Bernado M, et al. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T cell immune recovery. PLos One, 2017; 1-17.
Ali ZG, Boulassel MR. Factors associated with immune discordant responses in treated HIV-infected Omani patients. Open AIDS J, 2019; 13(1): 25–30.
Anusuya GS, Sikhamani R, Somani J, Gurusamy M, Nadol P, et al. Virological discordance in patients on first line antiretroviral therapy with Immunological failure in Tambaram, India. Natl J Res Comm Med, 2017; 6(1): 030–7.
Boatman J, Baker J, Emery S, Furrer H, Mushatt D, et al. Risk factors for low CD4+ count recovery despite viral suppression among participants initiating antiretroviral treatment with CD4+ counts > 500 cells/mm3: Findings from the Strategic Timing of AntiRetroviral Treatment (START) Trial. J Acquir. Immune Defic Syndr, 2019; 81(1): 10–17.
Guedes M, Carvalho SW, Andrade SJ, Maria BC, Souto F, Guimaraes R. Thymic exhaustion and increased immune activation are the main mechanisms involved in impaired immunological recovery of HIV-positive patients under ART. Viruses, 2023; 15(2): 440.
Darraj M, Shafer LA, Chan S, Kasper K, Keynan Y. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression. J Infect Public Health, 2018; 11(2): 265–9.
Adi N, Allahna E, Xun W, Emmanuel B, Yakubu A, et al. Clinical factors and outcomes associated with immune non response among virally suppressed adults with HIV from Africa and the United States. Scientific Reports, 2022; 12: 1196.
Chan P, Tang T, Kwong R, Chan L, Chan H, et al. Effects of syphilis infection among HIV-1-positive individuals on suppressive antiretroviral therapy. AIDS Research and Therapy, 2022; 19: 69.
Vila T, Sultan A, Jauregui D, Rizk MA. Oral candidiasis: A disease of opportunity. J Fungi, 2020; 6: 15.
Rozhana S, Bagui M N. Clinico-microbiological study on 100 HIV seropositive patients from Bangladesh. Kuwait Medical Journal 2019; 51(1): 66-71.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
